BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,551.5	$ 18,290.7	$ 42,816.9	$ 42,340.9
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,551.5	$ 18,290.7	$ 42,816.9	$ 42,340.9
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,265.0	$ 9,236.9	$ 21,319.0	$ 21,323.7
Percentage of total net sales and other revenue	49.90%	50.50%	49.80%	50.40%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,917.4	$ 5,919.4	$ 13,822.3	$ 13,808.7
Percentage of total net sales and other revenue	31.90%	32.40%	32.30%	32.60%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 2,132.0	$ 1,741.0	$ 4,754.8	$ 4,041.1
Percentage of total net sales and other revenue	11.50%	9.50%	11.10%	9.50%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 951.3	$ 1,126.8	$ 2,272.2	$ 2,527.2
Percentage of total net sales and other revenue	5.20%	6.10%	5.30%	6.00%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 285.8	$ 266.6	$ 648.6	$ 640.2
Percentage of total net sales and other revenue	1.50%	1.50%	1.50%	1.50%